Spectrum of Diverticular Disease. Outline

Similar documents
Aminosalicylates. Giovanni Barbara. Department of Medical and Surgical Sciences Alma Mater Studiorum, University of Bologna, Italy ( )

8/29/2016 DIVERTICULAR DISEASE: WHAT EVERY NURSE PRACTITIONER SHOULD KNOW. LENORE LAMANNA Ed.D, ANP-C LEARNING OBJECTIVES

Hits and Myths of Diverticulosis. JR Gray Gastoenterology UBC

DIVERTICULOSIS MEDICAL AND SURGICAL MANAGEMENT. Simon Radley Consultant Surgeon March 2013

Acute Diverticulitis. Andrew B. Peitzman, MD Mark M. Ravitch Professor of Surgery University of Pittsburgh

Aminosalicylates. V. Gross

How to differentiate Segmental Colitis Associated with Diverticulosis and Inflammatory Bowel Diseases?

Copyright note. Knut-Arne Wensaas (first author) Bergen,

Prof. Dr. Ahmed ElGeidie Professor of General surgery GEC Dr. Ahmed Abdelrafee

When should we operate for recurrent diverticulitis. Savvas Papagrigoriadis MD MSc FRCS Consultant Colorectal Surgeon King's College Hospital

When to Scope in Lower GI Bleeding: It Must Be Done Now. Lisa L. Strate, MD, MPH Assistant Professor of Medicine University of Washington, Seattle, WA

Diverticulosis Diverticulitis

Microbiome GI Disorders

Epidemiology and Treatment of Colonic Angiodysplasia; a Population-Based Study. Naomi G. Diggs, MD Lisa L. Strate, MD MPH March 2, 2010

Guideline scope Diverticular disease: diagnosis and management

5-aminosalicylic acid agents for prevention of recurrent diverticulitis: A systematic review and meta-analysis

Original Article. Page 1 of 6

Acute Care Surgery: Diverticulitis

Treatment of Inflammatory Bowel Disease. Michael Weiss MD, FACG

Small Bowel and Colon Surgery

Management of Diverticulitis. Sanjay Adusumilli MBBS MS FRACS

Motility Disorders In Diverticular Disease. M. Kreis. Ludwig-Maximilians Universität München Klinikum Großhadern, Chirurgische Klinik

Formulations and Availability 900 BILLION 5,319 HIGH POTENCY PROBIOTIC PEDIATRIC ADULT GERIATRIC PROVEN BY RESEARCH. HIGH-POTENCY. NO SHORTCUTS.

5/2/2018 SHOULD DEEP REMISSION BE A TREATMENT GOAL? YES! Disclosures: R. Balfour Sartor, MD

Implementation of disease and safety predictors during disease management in UC

Epidemiology of diverticulosis and diverticular disease. Alfredo Papa U.O.C. Medicina Interna e Gastroenterologia, C.I. Columbus

PELVIC PAIN : Gastroenterological Conditions

3/22/2011. Inflammatory Bowel Disease. Inflammatory Bowel Disease Objectives: Appendicitis. Lemone and Burke Chapter 26

Positioning Biologics in Ulcerative Colitis

NON INVASIVE MONITORING OF MUCOSAL HEALING IN IBD. THE ROLE OF BOWEL ULTRASOUND. Fabrizio Parente

Diverticular disease and colorectal cancer: incidental diagnosis or real association

Diverticular Disease: Looking beyond fiber

DIY Tricks of the Trade

Irritable Bowel Syndrome vs Inflammatory Bowel Disease

DIVERTICULAR DISEASE HANDS OFF OR HANDS ON?

The role of gut microbiome in IBS

Page 1. Is the Risk This High? Dysplasia in the IBD Patient. Dysplasia in the Non IBD Patient. Increased Risk of CRC in Ulcerative Colitis

Inflammatory Bowel Diseases (IBD) Clinical aspects Nitsan Maharshak M.D., IBD Center, Department of Gastroenterology and Liver Diseases Tel Aviv Soura

SBO and Diverticulitis (HBS edition) MINHAO ZHOU MD

Determinants of treatment: Outcome measures or how to read studies on diverticular disease

PELVIC PAIN : Gastroenterological Conditions

Complementary & Alternative Therapies in IBD

Endpoints for Stopping Treatment in UC

Crohn s Disease. Resident Lecture 1/17/19

Clinically proven to quickly relieve symptoms of common gastrointestinal disorders. TERRAGASTRO - Good health starts in the gut

Crohn s Disease: Should We Treat Based on Symptoms or Based on Objective Markers of Inflammation?

Primary Management of Irritable Bowel Syndrome

LONG TERM OUTCOME OF ELECTIVE SURGERY

UvA-DARE (Digital Academic Repository) Outcome and treatment of acute diverticulitis Ünlü, Çada. Link to publication

Fecal microbiota transplantation: The When,the How and the Don t. By Dr Rola Hussein

UNDERSTANDING X-RAYS: ABDOMINAL IMAGING THE ABDOMEN

Microscopic Colitis. Darrell S. Pardi, MD Inflammatory Bowel Disease Clinic Mayo Clinic

Personalized Medicine in IBD: Where Are We in 2013

Can We Predict the Natural History of Ulcerative Colitis? Edward V Loftus, Jr, MD Professor of Medicine Mayo Clinic Rochester, Minnesota, USA

IBD Understanding Your Medications. Thomas V. Aguirre, MD Santa Barbara GI Consultants

Corporate Medical Policy

The Best of IBD at UEGW (Crohn s)

Predicting the natural history of IBD. Séverine Vermeire, MD, PhD Department of Gastroenterology University Hospital Leuven Belgium

Disclosures. What Do I Do When Anti-TNF Therapy Is Not Working Anymore? Fadi Hamid, M.D. Saint Luke s GI Specialists

Diagnostic and Therapeutic Approaches to Dysplasia in Inflammatory Bowel Diseases

Does the Presence of Abscesses in Diverticular Disease Prelude Surgery?

Studies on inflammatory bowel disease and functional gastrointestinal disorders in children and adults Hoekman, D.R.

The role of Surgery and Stomas in IBD

Efficacy and Safety of Treatment for Pediatric IBD

Studies on inflammatory bowel disease and functional gastrointestinal disorders in children and adults Hoekman, D.R.

A clinical and radiological comparison of sigmoid diverticulitis episodes 1 and 2

Detection of Endoscopic and Histological Inflammation after an Attack of Colonic Diverticulitis is Associated with Higher Diverticulitis Recurrence

Diverticular Disease: An Update on Pathogenesis and Management

Mucosal healing: does it really matter?

INFLAMMATORY BOWEL DISEASE. Jean-Paul Achkar, MD Center for Inflammatory Bowel Disease Cleveland Clinic

Lectures: 1. Basic Endoscopic Ultrasonography (EUS) 2. EUS-FNA and therapeutic endoscopic ultrasound

A Trip Through the GI Tract: Common GI Diseases and Complaints. Jennifer Curtis, MD

Bloating, Flatulence, and

Understanding Inflammatory Bowel Diseases (IBD):

What Is Diverticulitis?

An Update on the Biologic Treatment for Patients with Inflammatory Bowel Disease. David A. Schwartz, MD

Surgery and Stomas in IBD When do I need it? Can I avoid it? How do I live with it?

A Population-Based Analysis of the Clinical Course of Colonic Diverticulitis and its Evolving Management

CRC and Dysplasia in IBD: Objectives of Talk. Colorectal Cancer and Dysplasia in IBD: A Case-Based Approach. Page 1

PEDIATRIC INFLAMMATORY BOWEL DISEASE

children Crohn s disease in MR enterography for GI Complications Microscopy Characterization Primary sclerosing cholangitis Anorectal fistulae

Mucosal Healing in Crohn s Disease. Geert D Haens MD, PhD University Hospital Gasthuisberg University of Leuven Leuven, Belgium

Uncomplicated diverticular disease is not a common cause of colonic symptoms

Gastrointestinal Diverticulosis A Retrospective Analysis

Does Fecal Microbiota Transplantation Cause Clinical Remission in Patients with Ulcerative Colitis?

Challenges in IBD: The Post-Op IBD Patient: Preventing Pouchitis & Recurrence

Nursing diagnosis for diverticular disease

Recent advances in the treatment of colonic diverticular disease and prevention of acute diverticulitis

Position of Biologics in IBD Circa 2006: Top Down vs. Step Up Therapy

Why FOCUS on Faeces! Wednesday 20 th May 2009

Inflammatory Bowel Disease When is diarrhea not just diarrhea?

Nutritional Requirements for Inflammatory Bowel Disease. Dale Lee, MD, MSCE Assistant Professor of Pediatrics University of Washington

Faecal Calprotectin. Reliable Non-Invasive Discrimination Between Inflammatory Bowel Disease (IBD) & Irritable Bowel Syndrome (IBS)

Surgical Management of IBD in the Age of Biologics

Definitions. Clinical remission: Resolution of symptoms (stool frequency 3/day, no bleeding and no urgency)

The Role of Surgery in Inflammatory Bowel Disease. Cory D Barrat, MD Colon and Rectal Surgeon Mercy Health

Common Questions in Crohn s Disease Therapy. Case

David Leff, DO. April 13, Disclosure. I have the following financial relationships to disclosure:

How do I choose amongst medicines for inflammatory bowel disease. Maria T. Abreu, MD

Dr David Epstein Vincent Pallotti Hospital and University of Cape Town

Transcription:

Spectrum of Disease ACG Postgraduate Course January 24, 2015 Lisa Strate, MD, MPH Associate Professor of Medicine University of Washington, Seattle, WA Outline Traditional theories and updated perspectives Recurrent diverticulitis Post-diverticulitis irritable bowel syndrome Symptomatic uncomplicated diverticular disease (SUDD) 1

Traditional View: Limited Acute Attacks 30-50% of Americans > 60 yrs Uncomplicated 75% Complicated 25-30% Asymptomatic 25% Bleeding 5% Colitis <1% Traditional View: Pathophysiology Obstruction / Trauma Bacterial stasis Microperforation Inflammation 2

Updated View: A Disease Spectrum Asymptomatic Symptomatic (SUDD) Recurrent Functional Bowel Disorders Bleeding Mood Disorders Colitis Evolving Pathophysiologic Mechanisms Disease Altered Microbiota Low-grade inflammation Disease Altered motility Visceral hypersensitivity Strate et al Am J Gastroenterol 2012 3

Updated View: A Disease Spectrum Asymptomatic Symptomatic Recurrent Irritable Bowel (SUDD) Syndrome Bleeding Mood Disorders Colitis Progression to is Uncommon 2222 Prevalent on colonoscopy Median time to event: 7 years 95 (4%) 6/1000 patient years 23 (1%) CT-confirmed 1.5/1000 patient years Shahedi K, et al Clin Gastroenterol Hepatol 2013 4

Are Antibiotics Necessary for Acute Uncomplicated? Multicenter randomized trial in Sweden 623 patients with CT proven uncomplicated L-sided diverticulitis Antibiotics N=314 No Antibiotics n=309 p value Complication (abscess, perforation) 3 (1.0%) 6 (1.9%) 0.30 Length of stay 3 days 3 days 0.72 Recurrence in 1 year 46 (16%) 47 (16%) 0.88 Chabok and AVOD study group BJS 2012 Updated View: A Disease Spectrum Asymptomatic Symptomatic Recurrent Irritable Bowel (SUDD) Syndrome Bleeding Mood Disorders Colitis 5

Recurrent is Not More Serious Than Incident Disease All Patients (n=20,135) < 40 years P value Recurrent admission 19% 27% <.001 More than 1 recurrence 3.8% 6.0% <.001 Recurrence with emergency colectomy 4.4% 6.7% <.001 Abscess 7.4% 11.2% <.001 30 day mortality 2.7% 0 <.001 A population-based administrative cohort (CHARS) in the state of Washington Anaya, Flum Arch Surg 2005 Timing of Elective Colectomy Decision analysis based on data from the population-based CHARS study Wait until at least 4 episodes Salem, Flum J Am Coll Surg 2004S 6

Diminished Role of Surgery in Recurrent The decision to recommend elective sigmoid colectomy after recovery from uncomplicated acute diverticulitis should be individualized Routine elective resection based on young age (< 50 years) is no longer recommended Practice guideline Amer. Society of Colon & Rectum Surgeons: Feingold, et al. Dis Colon Rectum 57(3); 2014: 284 Evolving Pathophysiologic Mechanisms Disease 5-ASA Low-grade inflammation Altered Microbiota Disease Probiotics Non-absorbable antibiotics Altered motility Visceral hypersensitivity Strate et al Am J Gastroenterol 2012 7

Summary: Prevention of Recurrent Fiber 5-ASA Rifaximin Probiotics Benefit?Prevent No benefit?prevent?prevent Type of evidence Indirect evidence from patients without previous diverticulitis Small Randomized Trials Meta-analyses Small trials rifaximin + fiber in patients with SUDD Small randomized trial Quality of evidence Low Moderate Low Low Giovanni M, et al. Dis Colon Rectum 2011; 54:1326 Mesalamine Does NOT Prevent Recurrent : PREVENT1 and PREVENT2 590/592 pts with 1 episode of diverticulitis in prior 2 yrs Mesalamine 1.2g, 2.4g or 4.8g 104 weeks (2 years) diagnosed by CT Raskin JB. Gastroenterology 2014;147:793 8

Updated View: A Disease Spectrum Asymptomatic Symptomatic Recurrent Irritable Bowel (SUDD) Syndrome Bleeding Mood Disorders Colitis IBS and Disease Motor abnormality Irritable bowel syndrome Altered colon structure/pressures Irritable bowel syndrome Post-inflammatory/ visceral hypersensitivity Irritable bowel syndrome Simpson et al Br J Surg 2003;90:899 9

Post- Irritable Bowel Syndrome Retrospective study of 1100 cases of diverticulitis and 1100 controls without a prior diagnosis of functional bowel disease followed for average of 6 years IBS: Adjusted HR 4.7 (95% CI, 1.6-14) Functional GI Diagnosis: Adjusted HR 2.4 (95% CI, 1.6-3.6) 23 cases 95 cases 4 controls 51 controls Cohen E, et al. Clin Gastro Hep 2013;11:1614 Post- & Mood Disorders Retrospective study of 1100 cases of diverticulitis and 1100 controls without a prior diagnosis of functional bowel disease followed for average of 6 years Depression/Mood Disorder: Adjusted HR 2.2 (95% CI, 1.4-3.6 ) 63 cases 35 controls Cohen E, et al. Clin Gastro Hep 2013;11:1614 10

Post- Quality of Life Spiegel BMR et al. Qual Life Res 2014 Updated View: A Disease Spectrum Asymptomatic Symptomatic Recurrent Irritable Bowel (SUDD) Syndrome Bleeding Mood Disorders Colitis 11

Symptomatic Uncomplicated Disease (SUDD) Subtype of diverticular disease with persistent abdominal symptoms attributed to diverticula in the absence of macroscopic colitis or diverticulitis Greater interest in Europe (UK and Italy) than US Variably applies to those with and without prior diverticulitis Spiller RC Dig Dis. 2012;30:64 IBS vs SUDD IBS SUDD Demographics Young Older Female >> Male Female = Male Colon structural changes No Yes Prevalence of symptoms 100% 15% of diverticulosis pts Rome criteria 100% 15% Pain pattern Frequent recurrences, short-lived Long remissions, prolonged (>24hrs) Pain location Diffuse Left lower quadrant Bowel alteration Diarrhea & constipation Diarrhea > constipation Fecal calprotectin Normal Elevated Spiller RDig Dis 2012;30:64-69 Tursi A J Clin Gastroenterol 2014 12

Summary: Treatment of SUDD Fiber 5-ASA Rifaximin Probiotics Benefit?Prevent Prevent Prevent Prevent Type of evidence Small studies; often combined with other therapy One small Randomized Trials One trial rifaximin + fiber; One RCT Few small randomized trial Quality of evidence Low Low Low Low Giovanni M, et al. Dis Colon Rectum 2011; 54:1326 Mesalamine & Lactobacillus casei Maintain Remission in SUDD 210 Italian patients with SUDD and no prior diverticulitis Treated 10 days/month x 12 months Mesalamine+Lactobacillus (n=54) Lactobacillus (n=55) Mesalamine (n=51) Placebo (n=50) Tursi A. Aliment Pharmacol Ther 2013;38:741 13

The Spectrum of Disease Altered Microbiota Inflammation Recurrent Segmental Colitis Altered Motility Hypersensitivity Symptomatic Uncomplicated (SUDD) Post- IBS Summary disease represents a spectrum of disorders with chronic manifestations Manifestations range from functional to frankly inflammatory Altered microbiota, chronic inflammation, visceral hypersensitivity and altered motility may play a role New treatment paradigms exist but few proven effective therapies 14

Updated View: A Disease Spectrum Asymptomatic Symptomatic Recurrent Irritable Bowel (SUDD) Syndrome Bleeding Mood Disorders Colitis Bleeding Associated with Cardiovascular Risk Factors Pathophysiology involves vascular injury and not mucosal inflammation Vessel histology consistent with arteriosclerosis Risk factors include: Obesity Physical inactivity Hypertension Hyperlipidemia Diabetes Strate et al. Gastroenterol 2008; 136:115 Strate et al. Am J Gastroenterol 2009; 104:1221 Yamada et al Dis Colon Rectum 2007; 51:116 15

Updated View: A Disease Spectrum Asymptomatic Symptomatic Recurrent Irritable Bowel (SUDD) Syndrome Bleeding Mood Disorders Colitis Colitis or Segmental Colitis Associated with Disease Chronic mucosal inflammation similar to IBD confined to a segment of (left) colon with diverticulosis with sparing of the rectum and proximal colon Diverticula are not inflamed (no diverticulitis) Relationship with IBD is unclear IBD with coincidental diverticulosis Segmental colitis is a form of IBD (10% develop IBD) Segmental colitis is a form of diverticulitis Sladen, et al. Dis Colon Rec 1984 Peppercorn et al. AJG 1992 16

Similarities IBD vs. Segmental Colitis Endoscopic findings Histology findings Treatment Differences Older age in SCAD SCAD spares rectum Lower relapse rate 5-ASA SCAD usually Antibiotics No fever Anti-TNF No ESR, CRP Tursi, et al. Dig Dis Sce 2011 17